Advertisement
Organisation › Details
Caixa Capital Risc
Caixa Capital Risc is a venture capital firm that invests in life sciences through its specialized fund Criteria Bio Ventures. Criteria Bio Ventures teams up with driven entrepreneurs to build innovative biotech companies that transform patients’ lives. Criteria Bio Ventures invests in international companies that provide disruptive therapeutic approaches centered on addressing unmet medical needs, with a primary focus on Europe. Caixa Capital Risc is part of the CriteriaCaixa group. *
Start | 2012-10-28 existent | |
Group | CriteriaCaixa (Group) | |
Industry | venture capital | |
Industry 2 | BIOTECH | |
Person | Armenter, Marcelino (Caixa 201906 Chairman of Caixa Capital Risc + CEO of CriteriaCaixa) | |
Person 2 | Cironi, Pablo (la Caixa 202205 Director of Life Science Investment Funds at Caixa Capital Risc) | |
Region | Barcelona | |
Country | Spain (España) | |
Street | 613 Avenida Diagonal 3° - B | |
City | 08028 Barcelona | |
Tel | +34-93-409-4060 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 215,000,000 (assets, managed (2019) 2019-06-26) | |
* Document for »About Section«: Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. | ||
Record changed: 2023-09-23 |
Advertisement
More documents for CriteriaCaixa (Group)
- [1] Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies....
- [2] Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA....
- [3] Ysios Capital. (9/24/18). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Guillem Laporta as Principal and Two New Venture Partners". Barcelona....
- [4] AptaTargets. (5/17/17). "Press Release: AptaTargets Closes €2.7 Million Round of Funding for New Stroke Treatment". Madrid....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top